Galapagos NV (ENXTAM:GLPG) entered into agreement to acquire CellPoint B.V. from ND Capital and others for approximately €230 million on June 21, 2022. All-cash transaction includes payment of an upfront amount of €125 million for CellPoint, including consideration for other liabilities associated with the transaction amounting to €10.3 million. Additional contingent consideration up to €100.0 million is due when certain development (€20.0 million), regulatory (€30.0 million) and sales-based (€50.0 million) milestones would be achieved. In a related transaction, Galapagos NV also acquired AboundBio, Inc. for $14 million (€13.1 million) in an all-cash transaction on June 21, 2022. Wilson Sonsini Goodrich & Rosati, P.C. acted as legal advisor to CellPoint. Rebecca Kuijpers-Zimmerman, Roel Meers, Oren Livne, and Els Janssens of Baker McKenzie acted as legal advisor to Galapagos NV.

Galapagos NV (ENXTAM:GLPG) completed the acquisition of CellPoint B.V. from ND Capital and others on June 21, 2022